[Current state and goals of the clinico-pharmacological evaluation of anti-arrhythmia and anti-angina agents].
D000319:Adrenergic beta-Antagonists / Q000097:blood / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000188:drug therapy*; D000889:Anti-Arrhythmia Agents / Q000097:blood / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D006801:Humans; D007700:Kinetics; D014665:Vasodilator Agents / Q000097:blood / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D003692:Delayed-Action Preparations; D014665:Vasodilator Agents
Sovremennoe sostoianie i zadachi kliniko-farmakologicheskogo izucheniia antiaritmicheskikh i antianginal'nykh preparatov.